Fevertree Drinks

Laura Hagan will step down from her mandate as a non-executive director at Fevertree Drinks at the end of July. She had served on the board since May 2021, was chair of the remuneration committee and a member of the audit and nomination committees. After her departure, David Lapp will assume the chair of the remuneration committee. » More on de.investing.com

Fevertree shares rose about 6.3% to 806.5 pence after the annual general meeting, driven by a trading update and the expansion of the buyback program. Management confirmed the brand is gaining market share in core regions and reiterated its full-year guidance. Analysts remain divided: some see significant upside potential, while others warn of high valuation multiples and declining revenue trends. » More on de.investing.com

Fevertree granted a total of 366,735 options over ordinary shares to the executive directors; CEO Tim Warrillow received 218,112 and CFO Andy Branchflower 148,623 options. The exercise price is 0.25 pence per share. The options form part of the Long Term Incentive Plan with a performance period from 1 January 2026 to 31 December 2028 and are scheduled to vest on 27 April 2029; the transactions were carried out off-market. » More on de.investing.com